In vitro antiproliferative efficacy of interferon-alpha, -gamma and tumor necrosis factor on two human renal tumor xenografts
- PMID: 2459829
- DOI: 10.1007/BF00263641
In vitro antiproliferative efficacy of interferon-alpha, -gamma and tumor necrosis factor on two human renal tumor xenografts
Abstract
The in vitro antitumor activity of recombinant alpha- and gamma-Interferon as well as recombinant Tumor Necrosis Factor alpha was tested on renal cell carcinoma xenografts using the double layer soft agar method. Using this assay, the effect of the drugs on the clonogenic potential of tumor cells in soft agar was determined and used as an indication for the antiproliferative capacity of these drugs. There appeared to be a differential response of the tested xenografts towards these drugs in a dose dependent way. However, when used in combination in most cases an additive or synergistic effect was observed. Even though again the response was differential, the combination of alpha-Interferon (10 ng/dish) and Tumor Necrosis Factor (100 ng/dish) resulted in a complete inhibition of colony formation in soft agar for both tumor lines. We conclude that there is a direct effect of alpha-Interferon, gamma-Interferon and Tumor Necrosis Factor on renal cell carcinoma xenografts. In combination drug tests the effect of alpha-Interferon and Tumor Necrosis Factor was strongly synergistic. The implication of these studies for in vivo use of these drugs remain to be established.
Similar articles
-
Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations.Urol Res. 1991;19(2):91-8. doi: 10.1007/BF00368183. Urol Res. 1991. PMID: 1906659
-
Effect of alpha- and gamma-interferon and tumor necrosis factor on colony formation of two human renal tumor xenografts in vitro.Semin Surg Oncol. 1988;4(3):195-8. doi: 10.1002/ssu.2980040311. Semin Surg Oncol. 1988. PMID: 3142009
-
Differential effects of human natural interferon-alpha and mismatched double-stranded RNA against a human renal cell carcinoma xenograft.Anticancer Res. 1990 May-Jun;10(3):795-801. Anticancer Res. 1990. PMID: 2369093
-
New prospects in the management of metastatic renal cell carcinoma. Experimental and clinical data.Prog Clin Biol Res. 1990;350:243-55. Prog Clin Biol Res. 1990. PMID: 2117284 Review. No abstract available.
-
Interferon treatment of renal cell carcinoma. Current status and future prospects.Cancer. 1987 Feb 1;59(3 Suppl):647-51. doi: 10.1002/1097-0142(19870201)59:3+<647::aid-cncr2820591313>3.0.co;2-#. Cancer. 1987. PMID: 10822464 Review.
Cited by
-
Enhanced in vivo cytotoxicity of recombinant human tumor necrosis factor with etoposide in human renal cell carcinoma. Evaluation in a pre-clinical model.Urol Res. 1990;18(4):245-50. doi: 10.1007/BF00294766. Urol Res. 1990. PMID: 2219586
-
Effects of high-energy shock waves combined with biological response modifiers or Adriamycin on a human kidney cancer xenograft.Urol Res. 1990;18(6):419-24. doi: 10.1007/BF00297376. Urol Res. 1990. PMID: 2100419
-
Concomitant treatment of MBT-2 bladder tumour by tumour necrosis factor alpha and interferon alpha in conjunction with delayed type hypersensitivity immunotherapy.Urol Res. 1991;19(1):57-62. doi: 10.1007/BF00294023. Urol Res. 1991. PMID: 1674182
-
Differential sensitivity of hormone-responsive and unresponsive human prostate cancer cells (LNCaP) to tumor necrosis factor.Urol Res. 1992;20(3):193-7. doi: 10.1007/BF00299716. Urol Res. 1992. PMID: 1615580
-
Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations.Urol Res. 1991;19(2):91-8. doi: 10.1007/BF00368183. Urol Res. 1991. PMID: 1906659
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical